These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 32292495)

  • 1. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression.
    Zhang Z; Qiu N; Yin J; Zhang J; Liu H; Guo W; Liu M; Liu T; Chen D; Luo K; Li H; He Z; Liu J; Zheng G
    Theranostics; 2020; 10(10):4290-4307. PubMed ID: 32292495
    [No Abstract]   [Full Text] [Related]  

  • 2. miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin.
    Du Q; Yuan Z; Huang X; Huang Y; Zhang J; Li R
    Anticancer Drugs; 2022 Mar; 33(3):308-319. PubMed ID: 34924500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRGN Promotes Colorectal Cancer Metastasis as a Critical Downstream Target of HIF-1α.
    Xu Y; Xu J; Yang Y; Zhu L; Li X; Zhao W
    Cell Physiol Biochem; 2018; 48(6):2429-2440. PubMed ID: 30121667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
    Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
    J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer.
    Zhu Y; Lam AKY; Shum DKY; Cui D; Zhang J; Yan DD; Li B; Xu WW; Lee NPY; Chan KT; Law S; Tsao SW; Cheung ALM
    Theranostics; 2021; 11(6):2722-2741. PubMed ID: 33456569
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
    Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
    Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
    Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
    J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
    Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
    J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.
    Guo JY; Hsu HS; Tyan SW; Li FY; Shew JY; Lee WH; Chen JY
    Oncogene; 2017 Apr; 36(17):2457-2471. PubMed ID: 27819672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
    Wu X; Wang Y; Zhong W; Cheng H; Tian Z
    Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1275 targets MDK/AKT signaling to inhibit breast cancer chemoresistance by lessening the properties of cancer stem cells.
    Han X; Li M; Xu J; Fu J; Wang X; Wang J; Xia T; Wang S; Ma G
    Int J Biol Sci; 2023; 19(1):89-103. PubMed ID: 36594100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA
    Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
    Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IQGAP1 overexpression attenuates chemosensitivity through YAP-mediated ferroptosis inhibition in esophageal squamous cell cancer cells.
    Li X; Zhao X; Su X; Wen J; Yang S; Qin Y; Yan S; Yao Y; Li X; Wang X
    Arch Biochem Biophys; 2024 Aug; 758():110064. PubMed ID: 38897534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression.
    Hayashi H; Higashi T; Yokoyama N; Kaida T; Sakamoto K; Fukushima Y; Ishimoto T; Kuroki H; Nitta H; Hashimoto D; Chikamoto A; Oki E; Beppu T; Baba H
    Cancer Res; 2015 Nov; 75(22):4985-97. PubMed ID: 26420216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
    Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
    Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1.
    Islam SS; Uddin M; Noman ASM; Akter H; Dity NJ; Basiruzzman M; Uddin F; Ahsan J; Annoor S; Alaiya AA; Al-Alwan M; Yeger H; Farhat WA
    EBioMedicine; 2019 May; 43():211-224. PubMed ID: 31085100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness.
    Kim T; Yang SJ; Hwang D; Song J; Kim M; Kyum Kim S; Kang K; Ahn J; Lee D; Kim MY; Kim S; Seung Koo J; Seok Koh S; Kim SY; Lim DS
    Nat Commun; 2015 Dec; 6():10186. PubMed ID: 26671411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells.
    Yang CE; Lee WY; Cheng HW; Chung CH; Mi FL; Lin CW
    Chem Biol Interact; 2019 Apr; 302():28-35. PubMed ID: 30703373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
    Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
    Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OTU deubiquitinase, ubiquitin aldehyde binding 2  (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression.
    Zhu W; Wu C; Liu Z; Zhao S; Huang J
    Cell Commun Signal; 2024 Aug; 22(1):420. PubMed ID: 39210373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.